Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
Value Creation in the Early Phase
China's booming biotech sector lures global pharma execs
Wednesday, June 20, 2018
Higher salary and more room for growth under an entrepreneurial environment are driving Chinese global pharma executives to domestic biotechs.
FiercePharmaAsia—Takeda, WuXi AppTec and more
Friday, June 1, 2018
Takeda investors voice concerns over Shire deal; WuXi AppTec becomes the largest-cap CRO; two families' wealth swells on Gardasil nods.
FiercePharmaAsia—Astellas, Brii's $260M, Sun and more
Friday, May 25, 2018
Astellas plots 600 job cuts in Japan; GSK's infectious disease lead launches a Chinese biotech; Sun Pharma's Zytiga rival wins the FDA's blessing.
FiercePharmaAsia—GSK, AstraZeneca, Samsung BioLogics
Friday, February 9, 2018
GSK is asked for more about its China bribery scandal, AZ made two health-tech deals in China, Samsung BioLogics' reported sales growth.
FiercePharmaAsia—Takeda, Shanghai Pharma, WuXi NextCODE
Friday, January 26, 2018
Takeda-Zinfandel dropped an Alzheimer’s study; Shanghai Pharma will open an R&D site in the U.S.; NextCODE CEO talked about company plans.
RSV vaccine player Codagenix snags $3M investment
Thursday, October 12, 2017
Young biotech Codagenix just secured $3 million in funding to advance its live-attenuated RSV vaccine candidate.
J&J labs resident Meissa nabs funds to advance RSV vaccine
Tuesday, August 8, 2017
Meissa Vaccines, a JLABS resident startup, has financial backing from the NIH and a VC firm to help advance its RSV vaccine candidate.
FiercePharmaAsia—Sun, Grail, InventisBio
Friday, June 2, 2017
Sun's U.S. sales dropped 34% last quarter, Grail is merging with Hong Kong-based Cirina, Shanghai-based InventisBio raised $19 million in series B.
Zomedica reels in $4M for pet drug development
Wednesday, August 31, 2016
Michigan-based Zomedica, a relatively new company focused on developing pet meds and complementary products, this week reeled in C$5 million ($4 million) as the first part of a share placement offering.